These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6090156)

  • 1. Binding of antimorphine anti-idiotypic antibodies to opiate receptors.
    Ng DS; Isom GE
    Eur J Pharmacol; 1984 Jun; 102(1):187-90. PubMed ID: 6090156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-morphine anti-idiotypic antibodies. Opiate receptor binding and isolated tissue responses.
    Ng DS; Isom GE
    Biochem Pharmacol; 1985 Aug; 34(16):2853-8. PubMed ID: 2992520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit anti-idiotypic antibodies raised against monoclonal anti-morphine IgG block mu & delta opiate receptor sites.
    Glasel JA; Myers WE
    Life Sci; 1985 Jul; 36(26):2523-9. PubMed ID: 2989638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-mimetic anti-paratypic antibodies: cross-reactive properties.
    Glasel JA; Pelosi LA
    Biochem Biophys Res Commun; 1986 May; 136(3):1177-84. PubMed ID: 3013170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal anti-idiotypic opioid receptor antibodies generated by the monoclonal beta-endorphin antibody 3-E7.
    Schulz R; Gramsch C
    Biochem Biophys Res Commun; 1985 Oct; 132(2):658-65. PubMed ID: 2998376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antimorphine antibodies on an in vitro correlate of antagonist-precipitated opiate abstinence.
    Killian AK; Schuster CR; Wainer BH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):820-7. PubMed ID: 7194910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarity between mu-opioid receptors in mouse vas deferens and guinea-pig ileum.
    Goodall J; Hughes IE; Mackay D
    Br J Pharmacol; 1985 May; 85(1):277-83. PubMed ID: 2992651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of mu opioid receptors in the mouse vas deferens for the study of opiate tolerance.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1989 Dec; 174(2-3):267-71. PubMed ID: 2560981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.
    Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA
    Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and properties of antimorphine anti-idiotypic antibodies and their antiopiate receptor activity.
    Glasel JA
    Methods Enzymol; 1989; 178():222-43. PubMed ID: 2557525
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-idiotypic opioid receptor antibodies.
    Schulz R; Gramsch C
    Neuropeptides; 1984 Dec; 5(1-3):221-4. PubMed ID: 6099502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference between mu-receptors in the guinea pig ileum and the mouse vas deferens.
    Sayre LM; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1983 May; 90(1):159-60. PubMed ID: 6307720
    [No Abstract]   [Full Text] [Related]  

  • 13. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
    Jin WQ; Chen XJ; Chi ZQ
    Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate receptor binding studies in the mouse vas deferens exhibiting tolerance without dependence.
    Rubini P; Schulz R; Wüster M; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):142-6. PubMed ID: 6287304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proglumide exhibits delta opioid agonist properties.
    Rezvani A; Stokes KB; Rhoads DL; Way EL
    Alcohol Drug Res; 1987; 7(3):135-46. PubMed ID: 3030338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CI-977, a novel and selective agonist for the kappa-opioid receptor.
    Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
    Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some aspects of opiate receptors.
    Herz A; Schulz R; Wüster M
    Adv Biochem Psychopharmacol; 1980; 21():329-37. PubMed ID: 6246748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus.
    Mackerer CR; Brougham LR; East PF; Bloss JL; Dajani EZ; Clay GA
    J Pharmacol Exp Ther; 1977 Dec; 203(3):527-38. PubMed ID: 200732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.